Helen Stephens Group »

Arbutus Biopharma shares owned by Helen Stephens Group

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Helen Stephens Group from 13F filings

Historical chart of Helen Stephens Group investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Helen Stephens Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Helen Stephens Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $50k 13k 3.85

More positions owned by Helen Stephens Group

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Core S&p Us Gwt (IUSG)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
J P Morgan Exchange Traded F Municipal Etf (JMUB)
Dimensional Etf Trust Us Real Estate E (DFAR)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Shrt Nat Mun Etf (SUB)

View all positions for Helen Stephens Group

Top funds holding Arbutus Biopharma

Morgan Stanley
Whitefort Capital Management
BlackRock
BlackRock
Two Seas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
BlackBarn Capital Partners
Rubric Capital Management
Squarepoint Ops
Advisor Group Holdings
Northern Trust
Charles Schwab Investment Management
Hudson Bay Capital Management

View all funds holding Arbutus Biopharma